Author

W. Sebastian Doherty-Boyd

University of GlasgowORCID 0009-0002-4831-7480Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adam G. WestiD· 1 shared Aline F. Miller· 1 shared Aqeel F. Taqi· 1 shared Hannah DonnellyiD· 1 shared Manuel Salmerón‐SáncheziD· 1 shared Matthew John DalbyiD· 1 shared Matthew WalkeriD· 1 shared Niall Mahon· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Adam G. WestORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringBiomaterialsPeer-reviewedOct 26, 2025

Synthetic peptide hydrogels as a model of the bone marrow niche demonstrate efficacy of a combined CRISPR-CAR T-cell therapy for acute myeloid leukaemia

W. Sebastian Doherty-Boyd, Penelope M. Tsimbouri, Vineetha Jayawarna…·Hannah Donnelly

The paper develops a synthetic BM niche model to test CRISPR-CAR T-cell therapy for AML, showing its efficacy in a human-like environment.

3 citations

humanexperimental assay

𝕏 PostBluesky